Advertisement

Topics

Garching Innovation GmbH Company Profile

23:10 EST 24th November 2017 | BioPortfolio

GI was founded in 1970. It consists of an interdisciplinary team of scientists, business people, and lawyers. The company's authorized capital stock amounts to EUR 51,129.19 GI concludes agreements in its own name to the account of the MPS. Income from license agreements is transferred to the MPS. The MPS subscribes to the company shares it acquires during licensing negotiations. An advisory board consisting of politicians, scientific experts, and business representatives monitors the work of GI.

Location

Technologien aus derMax-Planck-Gesellschaft
Marstallstraße 8
Munich
80539
Germany

Contact

Phone: 49 / 89 / 29 09 19-0
Fax: 49 / 89 / 29 09 19-99
Email: gi@garching-innovation.de


News Articles [406 Associated News Articles listed on BioPortfolio]

Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug testing

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a mul...

Daiichi Sankyo, Max Planck Innovation GmbH And Lead Discovery Center Announce Cancer Research Collaboration

  Life Sciences Jobs   ...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Proteros teams up with Johnson & Johnson Innovation on sub-class of epigenetic targets

Proteros biostructures GmbH announced today that the company has entered into a collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, on a sub-cl...

Xerox, PARC Partners with Innovation Lab to Develop Innovation Healthcare Solutions

Xerox Corporation and PARC, A Xerox Company are teaming up with Innovation Lab, an Innovation Institute company, to tackle health care challenges through collaboration in medical technology, engineeri...

SÜSS MicroTec-Aktie: Leerverkäufer JPMorgan Asset Management hat den Rückwärtsgang eingelegt - Aktiennews

Garching bei München - Leerverkäufer JPMorgan Asset Management (UK) Ltd baut Netto-Leerverkaufsposition in Aktien der SÜSS MicroTec AG etwas ab: Die Finanzprofis von JPMorgan Asset Management (UK) ...

How universities are fostering innovation and entrepreneurship

(University of South Florida (USF Innovation)) Technology and Innovation 19.1 zeroes in on innovation and entrepreneurship, with a special focus on what universities are currently doing to foster grow...

MD Anderson chief innovation officer: “Innovation doesn’t have to be sexy”

Rebecca Kaul, chief innovation officer at MD Anderson Cancer Center and a keynote speaker at MedCity CONVERGE, discussed why innovation is needed in healthcare — particularly in the oncology spac

PubMed Articles [211 Associated PubMed Articles listed on BioPortfolio]

Creating a climate that catalyses healthcare innovation in the United Kingdom - learning lessons from international innovators.

The United Kingdom (UK) lags behind other high-income countries in relation to technological innovation in healthcare. In order to inform UK strategy on how to catalyse innovation, we sought to unders...

Young children's tool innovation across culture: Affordance visibility matters.

Young children typically demonstrate low rates of tool innovation. However, previous studies have limited children's performance by presenting tools with opaque affordances. In an attempt to scaffold ...

The sociology of space as a catalyst for innovation in the health sector.

This paper reviews the role of space in facilitating innovation. It draws on the sociology of space in exploring the social practices, institutional forces and material complexity of how people and sp...

Network analysis of surgical innovation: Measuring value and the virality of diffusion in robotic surgery.

Existing surgical innovation frameworks suffer from a unifying limitation, their qualitative nature. A rigorous approach to measuring surgical innovation is needed that extends beyond detecting simply...

Modelling innovation performance of European regions using multi-output neural networks.

Regional innovation performance is an important indicator for decision-making regarding the implementation of policies intended to support innovation. However, patterns in regional innovation structur...

Clinical Trials [137 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Childhood Obesity Prevention Trough Education Innovation in Primary School: A Quasi-experimental Trial

This study evaluates the effect of the education innovation program"chiquichefs" on anthropometric variables, quality of life and nutritional habits in an elementary school children. Compa...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Satiety Innovation- Study 793. University of Aberdeen

The proposed study will address the effect of developed novel food products through processing innovation on motivation to eat, biomarkers of satiety, nutrient bioavailability and gut heal...

SATIN: Satiety Innovation. Study 2- University of Aberdeen

The proposed study will address the effect of developed novel food products through processing innovation on motivation to eat, biomarkers of satiety, nutrient bioavailability and gut heal...

Companies [1424 Associated Companies listed on BioPortfolio]

Garching Innovation GmbH

GI was founded in 1970. It consists of an interdisciplinary team of scientists, business people, and lawyers. The company's authorized capital stock amounts to EUR 51,129.19 GI concludes agreements in...

Max-Planck-Innovation GmbH

Max-Planck-Innovation GmbH is the technology transfer agencyof the Max Planck Society (MPS). Max-Planck-Innovation organizes the transfer of new ideas and inventions to industrial products. Issuing li...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

flyion GmbH

flyion is a spin-off from the Institute of Physiology at the University of Tübingen. The company was founded in February 2001 as a limited liability company (GmbH) in Tübingen, Germany, by Dr. Albre...

Bayer Innovation GmbH

Nil

More Information about "Garching Innovation GmbH" on BioPortfolio

We have published hundreds of Garching Innovation GmbH news stories on BioPortfolio along with dozens of Garching Innovation GmbH Clinical Trials and PubMed Articles about Garching Innovation GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Garching Innovation GmbH Companies in our database. You can also find out about relevant Garching Innovation GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record